Legal Opinion
Organon Inc. v. Mylan Pharmaceuticals, Inc.
District Court, D. New Jersey
Decided December 3, 2003No. CIV.A. 01-2171(FSH), CIV.A. 01-3835(FSH), CIV.A. 01-2682(FSH), CIV.A. 01-4246(FSH)PublishedCited by 16 opinions
1Opinion of the Court
OPINION
HOCHBERG, District Judge.
This matter comes before the Court upon Plaintiffs Organon Inc. 1 and Akzo Nobel N.V.’s (together, “Organon”) Motion to Dismiss Defendants’ counterclaims for antitrust and other state law violations, pursuant to Fed.R.Civ.P. 12(b)(6) for failure to state a claim. Pursuant to Fed.R.Civ.P. 78, this Court has reviewed the submissions of the parties.
BACKGROUND
Organon manufactures the antidepressant drug mirtazapine, 2 which was originally claimed in its now-expired United States Patent No. 4,062,848 (the “ ’848 patent”). Organon filed a New Drug Application (“NDA”)…
2Cases cited22 opinions
- Warth v. SeldinSupreme Court of the United States · 1975
- Hishon v. King & SpaldingSupreme Court of the United States · 1984
- Pension Benefit Guaranty Corporation v. White Consolidated Industries, Inc., C/o Ct Corporation Systems Registered AgentCourt of Appeals for the Third Circuit · 1993
- Christiansburg Garment Co. v. Equal Employment Opportunity CommissionSupreme Court of the United States · 1978
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
17 more not listed; retrieve them via the Exa API.
3Cited by16 opinions
- Nader v. the Democratic Nat. CommitteeDistrict Court, District of Columbia · 2008
- In Re Gabapentin Patent LitigationDistrict Court, D. New Jersey · 2009
- Otsuka Pharmaceutical Co. v. Torrent Pharmaceuticals Ltd.District Court, D. New Jersey · 2015
- In Re Terazosin Hydrochloride Antitrust LitigationDistrict Court, S.D. Florida · 2004
- Walgreen Co. v. Organon, Inc.District Court, D. New Jersey · 2004
11 more not listed; retrieve them via the Exa API.